Gene Query: EIF3M

Dataset Description Geneva Score
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 40.49
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 29.82
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 28.77
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 28.63
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 28.46
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 28.18
Co-transcriptional loading of RNA export factors shapes the human transcriptome 27.97
RNAseq of HEK293 cells after Chtop knockdown 27.97
RIG-I and MDA5 fRIP during KSHV lytic reactivation 26.63
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 22.93
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 20.99
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 20.85
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 20.05
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 19.63
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 19.61
3’ Uridylation Expands miRNA Target Repertoire 19.3
Ribosomal footprinting of MDA-Parental and MDA-LM2 18.6
Ribosomal footprinting of CN34-Parental and CN34-LM1a 18.56
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 16.74
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 16.6
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 16.49
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 16.47
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 16.47
Single-nucleotide-resolution mapping of HBV promoters using CAGE 16.35
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 16.24
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 15.29
Role of microRNAs in the interaction between Salmonella and the host cell 15.17
Global analysis of enhancer targets: Mosaic-seq 14.74
Sensing self and nonself circular RNAs 14.58
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 14.51
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 14.3
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 14.19
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 14.19
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 13.94
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 13.85
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 13.85
RNA sequencing of primary human platelets and in vitro cell lines 13.52
Transcriptomic analysis of the HOTAIR-regulated genes 13.38
Dtx3L and Androgen Signaling in Prostate Cancer 13.23
RNA-Seq with and without RNase treatment in PCa cell lines 13.14
Differetially expressed genes after hTR overexpression in U2OS cells 13.06
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 13.06
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 12.96
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 12.93
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 12.76
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 12.72
RNA-seq analysis of BAP1-depleted uveal melanoma cells 12.68
Human cell line and subcutaneous tumor 12.66
NRDE2 negatively regulates nuclear exosome functions 12.65
Short and Long RNA sequencing of human mature erythrocytes 12.56
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 12.3
Mitochondrial dsRNA triggers antiviral signalling in humans 12.07
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 12.06
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 11.99
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 11.9
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 11.69
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 11.58
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 11.53
RNA-Seq analysis of breast cancer cells after shikonin treatment 11.52
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 11.49
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 11.41
CROP-Seq in Primary Human T Cells 11.39
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 11.3
Transcriptome of U251 cells overexpression complement component 7 11.27
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 11.22
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 11.16
mRNA expression profile of Lymphocytes 11.08
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 10.97
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 10.97
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 10.96
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 10.84
Next generation sequencing of small RNAs isolated from exosomes in human semen 10.8
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 10.78
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 10.75
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 10.6
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 10.6
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 10.54
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 10.54
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 10.31
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 10.28
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 10.24
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 10.22
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 10.15
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 10.05
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 10.05
Profiling of escape kinetics of viruses subjected to RNAi 10.0
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 9.97
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 9.91
Effect of Hotair overexpression in human breast cancer cell lines 9.87
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 9.85
RNA-seq analysis of differentiating human erythroblasts 9.69
RNA-seq melanoma 9.67
RNA m5C Methylation in breast cancer using MeRIP-Seq 9.64
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 9.59
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 9.59
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 9.56
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 9.46
Depicting early human development and germ cell origin with porcine embryos 9.41
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 9.39
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 9.26
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 9.24
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 9.17
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 9.15
LncRNA expression profiling of ischemic stroke patients 9.15
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 9.14
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 9.13
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 9.13
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 9.11
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 9.11
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 9.02
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 9.02
Genes significantly down or Up-regulated upon RNF219 knockdown 9.02
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 8.86
Role of XRN2 ribonucleolytic activity in RNA metabolism 8.86
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 8.85
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.81
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 8.74
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 8.71
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 8.71
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 8.7
Novel Targeting of Transcription and Metabolism in Glioblastoma 8.68
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 8.64
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 8.64
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 8.59
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 8.59
Exploring the RNA landscape of endothelial exosomes 8.58
Identification of renal resident macrophages across species 8.52
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 8.41
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.38
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 8.37
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 8.37
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 8.37
Determination of tRNA aminoacylation levels by high throughput sequencing 8.36
The human blood-nerve barrier transcriptome 8.34
mRNA expression in human DAOY cells 8.26
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 8.22
Genome-wide discovery of human splicing branchpoints [RNAse] 8.08
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 8.08
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 8.0
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 7.99
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 7.98
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 7.98
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 7.96
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 7.96
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 7.93
Peptidomimetic blockade of MYB in acute myeloid leukemia 7.85
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 7.85
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 7.72
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 7.71
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 7.71
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 7.69
hnRNP C is a key regulator of protein synthesis in mitosis 7.66
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 7.66
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 7.63
Paxillin regulates genomic networks in prostate cancer [LNCaP] 7.6
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 7.55
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 7.48
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 7.46
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 7.35
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 7.35
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 7.33
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 7.33
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 7.25
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 7.22
Identification of Atrial Fibrillation associated genes and functional non-coding variants 7.12
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 7.1
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 7.1
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 7.1
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 7.09
Identification of transcription start sites for human A549 cell line using ReCappable-seq 7.08
Developmental stage specific chromosome architecture in human erythroid cells 7.0
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 7.0
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 6.99
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 6.95
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 6.94
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 6.92
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.87
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 6.85
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 6.8
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 6.78
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 6.77
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.71
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.71
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 6.67
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 6.63
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 6.63
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 6.59
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 6.58
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 6.56
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 6.56
METTL3 and WTAP 6.54
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 6.53
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 6.45
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 6.42
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 6.4
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 6.4
An acquired vulnerability of drug resistant melanoma with therapeutic potential 6.4
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 6.39
Transcriptome of activated human and mouse MAIT cells 6.39
RNA-seq of RKO cells with cTAZ KO or putback 6.38
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 6.38
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 6.38
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 6.35
Transcriptomic analyssis following EHMT1/2 inhibition 6.33
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 6.28
Global Mapping of Human RNA-RNA Interactions 6.28
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 6.27
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 6.27
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 6.27
Differential gene expression profiles in imatinib-resistant cell lines 6.23
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 6.17
Regulatory network controlling tumor-promoting inflammation in human cancers 6.17
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 6.14
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 6.12
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 6.1
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 6.08
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 6.02
In vitro modeling of human germ cell development using pluripotent stem cells 6.02
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 6.01
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 5.93
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 5.91
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 5.91
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 5.91
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 5.89
The pioneer factor CEBPA modulates vitamin D signaling 5.85
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 5.85
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 5.71
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 5.65
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 5.65
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 5.64
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 5.64
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 5.62
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 5.56
SLAM-seq for K562 endogenous mRNA decay 5.54
RNA transcriptome analysis during HSV-1 infection 5.52
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 5.51
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 5.42
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 5.42
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 5.37
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 5.33
Human cells contain natural double-stranded RNAs with potential regulatory capacity 5.32
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 5.31
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 5.29
Gene expression analysis of human liver progenitor-like cells in culture 5.23
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 5.22
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 5.2
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 5.2
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 5.16
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.15
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 5.11
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 5.1
Reassessment of Exosome Composition 5.04
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 5.03
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 5.02
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 4.95
Molecular Criteria for Defining the Naive Human Pluripotent State 4.93
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 4.84
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 4.81
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 4.77
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 4.77
CDK12 mediated transcriptional regulation in U2OS cells 4.72
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 4.72
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 4.72
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 4.71
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 4.71
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 4.69
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 4.65
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 4.65
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 4.64
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 4.6
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 4.57
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 4.57
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 4.55
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 4.52
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 4.52
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 4.46
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 4.44
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 4.41
HEK293 Heat-shock experiment 4.39
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 4.37
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 4.36
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 4.36
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 4.36
Exogenous rescue of KLHL9 in SF210 cell line 4.33
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 4.28
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 4.28
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 4.28
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 4.26
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 4.24
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 4.18
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 4.15
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 4.11
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 4.07
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 4.0
Unique features and clinical importance of acute alloreactive immune responses 3.96
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 3.95
Ribosome profiling upon inhibition of eIF4A 3.95
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 3.94
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 3.94
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 3.9
Role of cervicovaginal microbiota in genital inflammation 3.89
Transcriptome analysis of peripheral blood monocytes 3.88
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 3.87
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 3.85
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 3.85
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 3.85
RNA sequencing of mechanically strained NHEKs and control NHEKs 3.84
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 3.79
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 3.77
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 3.77
RNA-seq analysis of breast cancer 3.76
RNA-seq analysis and shRNA screen of breast cancer 3.76
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 3.75
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 3.73
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.72
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 3.69
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.65
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 3.59
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 3.59
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 3.58
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 3.58
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.55
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 3.5
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 3.47
RNA-Seq of PRMT1 overexpression ECA109 cells 3.25
Metabolism as an early predictor of DPSCs aging 3.15
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 3.06
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 3.04
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 3.02
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.99
Transposon-based construction of strand-specific RNA-seq libraries 2.97
Cell responses to dysregulated VZV-induced cell-cell fusion 2.95
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.95
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.91
ADAR1-editing of cellular and measles virus-derived duplex RNA 2.87
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 2.87
An siRNA screen identifies CHD4 as a target for epigenetic therapy 2.82
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 2.81
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.79
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.77
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.77
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 2.73
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 2.72
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 2.72
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 2.65
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 2.64
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 2.63
Differentiation enhances Zika virus infection in neuronal brain cells 2.59
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 2.58
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 2.53
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 2.52
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 2.51
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 2.51
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 2.5
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 2.48
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 2.41
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 2.3
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 2.28
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.28
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 2.25
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 2.24
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.23
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.22
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 2.2
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 2.16
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 2.16
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 2.12
The transcriptome and chromatin accessbility landscape of mammalian germline 2.12
p63 controls the enhancer landscape during keratinocyte differentiation 2.05
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.02
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 2.0
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.98
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.95
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.95
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 1.92
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.91
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 1.88
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 1.88
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.87
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.85
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.83
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.8
MicroRNA-125a-5p overexpression in human macrophages 1.79
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.79
Identification of the role of polydom in neurofibromas 1.77
RNA-seq of naive and primed ES cells 1.75
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.72
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.69
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.67
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.66
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.66
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.64
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.64
naive T cell heterogeneity after neonatal thymectomy 1.63
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.63
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.63
Myc activation coordinates gene transcription and protein translation responses 1.59
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.56
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.56
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 1.55
Gene expression analysis of human adenomas. 1.51
Comparative Analysis of Cas9 Activators Across Multiple Species 1.46
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.46
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.41
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.4
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.4
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.4
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.35
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.35
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 1.35
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.32
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.3
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 1.29
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.28
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.27
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 1.25
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.24
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.21
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.2
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.17
RNA-Seq from human ILC transitional populations 1.17
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 1.16
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.14
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.13
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 1.08
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.05
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.05
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.04
Transcription elongation regulates genome 3D structure 1.0
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 0.92
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 0.92
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.92
MARS Seq data from human cortical organoids 0.9
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.9
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.88
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.88
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.87
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.87
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.87
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.82
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.81
High-resolution comparative analysis of great ape genomes 0.81
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.8
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.8
siRNA-mediated knockdown 0.79
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 0.78
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.77
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 0.76
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 0.76
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 0.73
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 0.73
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.69
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.68
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.66
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.66
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.52
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 0.52
RNAseq of cell lines with knocked in ESR1 mutations 0.52
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.51
Transcriptome analysis of CNS leukemia 0.51
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 0.51
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.5
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.5
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.5
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.5
RNA-seq of primary patient AML samples 0.47
MARCKS and lnc-MARCKS act as inflammation regulators 0.47
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.45
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.42
Gene expression alterations of pancreatic intraepithlial neoplasia 0.4
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.38
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.38
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.35
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.33
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.25
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.25
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 0.24
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.2
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.2
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.16
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.15
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.15
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.14
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.14
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.13
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.13
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.13
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.12
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.11
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.08
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.08
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.07
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.04
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.04
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.04
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 0.02
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.01
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.01
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.0
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation